Finall Exam:l NRl 566l NR566l Latestl

Finall Exam:l NRl 566/l NR566l (Latestl

2026/l 2027l Update)l Advancedl Pharmacologyl forl Carel ofl thel Familyl Guide|l Q/Al |l Gradel A|l 100%l Correctl (Verifiedl Answers)l -Chamberlain

Q:l betal adrenergicl blockingl agentsl adversel effects

Answer:

Local:l eyel stringing,l conjunctivitis,l blurredl vision,l photophobia,l dryl eyes Systemic:l Heartl andl lungsl ifl absorbedl inl sufficientl amountsl (bradycardia,l bronchospasm) Cardioselectivel agentsl (betaxololl andl levobetaxolol)l recommendedl forl asthmal patients

Q:l Prostaglandinl analogl sidel effects

Answer:

heightenedl brownl pigmentationl ofl thel irisl andl eyelid

Q:l Ocularl Decongestantsl Contraindications

Answer:

Patientsl withl al historyl ofl angle-closurel glaucoma

Q:l Histamine-1l (H1)-receptorl antagonistsl MOA

Answer:

Blockl H1l receptorsl andl preventl mediatorl releasel froml mastl cells

• / 4

Q:l Benzoyll Peroxidel Indications

Answer:

-l al first-linel drugl forl mildl tol moderatel acne -l isl bothl anl antibioticl andl keratolytic.l -l Improvementl canl bel seenl withinl daysl ofl startingl treatment.

Q:l Acnel Combinationl Therapy

Answer:

-combinationl OCl canl bel usedl tol txl ifl acnel unresolvedl byl otherl drugsl -otherl combos:l clindamycin/benzoyll peroxidel &l erythromycin/benzoyll peroxide

Q:l Acnel topicall agentl indications

Answer:

Q:l acnel -l topicall keratolyticl agentsl function

Answer:

-l Keratolyticl agentsl arel drugsl thatl helpl promotel thel sheddingl ofl thel outerl layerl ofl thel skin -l usedl tol treatl overgrowthl orl abnormall thickeningl ofl thel skin -l treatl skinl conditionsl likel acne,l psoriasis,l dandruff,l orl seborrheicl dermatitis -l Keratolyticl agentsl inl higherl concentrationsl canl treatl orl removel warts,l calluses,l andl corns.

Q:l otitisl external topicall medications

Answer:

-2%l aceticl acid -morel extensivel infection,l addl topicall antibioticl (fluoroquinolonel &l glucocorticoid)

• / 4

Q:l firstl generationl antipsychoticsl MOA

Answer:

Blockl dopamine,l acetylcholine,l histamine,l andl norepinephrinel receptorsl inl thel brainl andl periphery

Q:l First-Generationl Antipsychoticsl Primaryl Indication

Answer:

schizophrenia -2l tol 4l weeksl tol seel improvementl butl canl takel months

Q:l first-genl antipsychoticsl therapeuticl effect

Answer:

decreasedl ofl positivel symptoms

Q:l firstl genl antipsychoticsl adversel effectsl (4l s/s)

Answer:

EPS:

-l acutel dystonia:l musclel spasm

-l Parkinsonism:l shufflingl gait/drooling

-l akathisia:l restlessl movement

-l tardivel dyskinesia:l oral-faciall dyskinesiasl

&l NMS

Q:l tardivel dyskinesia

Answer:

involuntaryl choreoathetoidl (movementsl ofl thel faciall muscles,l tongue,l andl limbs)

-tx:l valbenazine 3 / 4

Q:l Neurolepticl Malignantl Syndromel (NMS)

Answer:

-leadl pipel rigidityl w/l suddenl highl fever,l sweating,l andl autonomicl instability -dysrhythmiasl &l fluctuationsl inl BP

Q:l Treatmentl forl NMS

Answer:

-coolingl measures -w/drawll ofl antipsychoticl -fluids -benzos -dantrolene/pramipexole

Q:l Treatmentl forl tardivel dyskinesia

Answer:

Valbenazine:l Somnolence

Deutetrabenazine

-l CI:l hepaticl impairment

-l warnings:l somnolence

Q:l neonatall withdrawall symptomsl (6)

Answer:

-tremors -agitationl -sleepiness -difficultyl w/l feeding -severel breathingl difficultyl -alteredl musclel tone

• / 4